Tirzepatide is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This novel class of therapeutic agents, known as twincretins, has been developed to enhance the physiological regulation of blood glucose and body weight by acting on two complementary incretin pathways. Research involving tirzepatide has demonstrated significant improvements in insulin sensitivity, glycemic control, and appetite regulation, making it highly relevant in studies addressing metabolic disorders…
Description Tirzepatide is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This novel class of therapeutic agents, known as twincretins, has been developed to enhance the physiological regulation of blood glucose and body weight by acting on two complementary incretin pathways. Research involving tirzepatide has demonstrated significant improvements in insulin sensitivity, glycemic…
